Ads
related to: pharmaceuticals
Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Detroit News· 17 hours agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest effort by the Biden administration targeting
Mark Cuban Cost Plus Drug Company to Supply ScionHealth Utilizing Safecor Health Program
WKBN 27 Youngstown· 13 hours agoScionHealth announced today they will begin purchasing certain bulk drugs from Mark Cuban's Cost Plus Drug Company ("Cost Plus Drugs") and delivered to Safecor Health's SafecorLogics program ...
DC/Dox Film Festival Unveils Second Annual Lineup (EXCLUSIVE)
Variety via AOL· 17 hours agoDC/Dox has unveiled the lineup for its second annual edition, which takes place in Washington, D.C.,...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 1 day agoWASHINGTON — Federal regulators are challenging patents on 20 brand-name drugs, including the...
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
Investor's Business Daily· 12 hours agoDecades of market research reveals that the best-performing stocks typically have an RS Rating north...
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Reuters· 1 day ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the ...
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 16 hours agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Enliven Therapeutics chief scientific officer sells over $200k in stock By Investing.com
Investing.com· 7 hours agoEnliven Therapeutics, Inc. (NASDAQ:ELVN) has reported a significant transaction by Chief Scientific...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 1 day agoHEALTH NEWS The Federal Trade Commission is challenging hundreds of pharmaceutical patent listings...